Rani Therapeutics Holdings Inc (RANI) — Cash Flow Reinvestment Rate
Latest as of September 2020:
0.15x
Rani Therapeutics Holdings Inc (RANI) has a Cash Flow Reinvestment Rate of 0.15x as of September 2020, reinvesting $99.00K (capex $99.00K ) from operating cash flow of $670.00K. Explore cash flow conversion of Rani Therapeutics Holdings Inc to assess how effectively this company generates cash.
Reinvestment Rate
0.15x
(Capex + Investments) / Operating CF
Total Reinvested
$99.00K
Capex + Investments
Operating Cash Flow
$670.00K
USD
Capital Expenditures
$99.00K
USD
Annual Cash Flow Reinvestment Rate for Rani Therapeutics Holdings Inc (None–None)
Year-by-year capital reinvestment analysis for Rani Therapeutics Holdings Inc. For live market cap and broader valuation context, see market cap of Rani Therapeutics Holdings Inc.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow